Revenue
1.66 million USD
2026 Q2 · USD
Exact inputs and evidence
- Revenue: 1657000 USD Source
Annual consolidated revenue for 2025: about USD 1.395M, using the latest reported figures. The previous period, 2024, was about USD 276K.
1.66 million USD
2026 Q2 · USD
-53.59%
2026 Q2 · %
-776 thousand USD
2026 Q2 · USD
1553000 USD
67400 USD
42003934 shares
23.58% · 8.02 million shares
Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.
The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.
4 million USD
2025-07-01 – 2026-06-30
-7.74 million USD
2025-07-01 – 2026-06-30
-3.5 million USD
2025-07-01 – 2026-06-30
Includes later revisions to earlier periods. Annual charts exclude incomplete years.
Latest filing recorded: 2026-10-23.
Financial data available through: 2025-12-31.
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Prior period
USD 276,000
–
Current period
USD 1.4 million
–
1395000 − 276000 = 1119000 USD
276000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source1395000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
−USD 8.93 million
–
Current period
−USD 7.92 million
–
-7920000 − -8933000 = 1013000 USD
-8933000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source-7920000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
−USD 7.46 million
–
Current period
−USD 4.89 million
–
-4889000 − -7457000 = 2568000 USD
-7457000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source-4889000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Comparable inputs unavailable for: Capital expenditure.
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
| Period | Revenue | Operating costs | Operating income | Tax, interest and other | Net income | Free cash flow | Source |
|---|---|---|---|---|---|---|---|
| 2018 2018-01-01 – 2018-12-31 | 253785 | 2300292 Derived | -2046507 | 464616 Derived | -2511123 | Unavailable | Source
|
| 2019 2019-01-01 – 2019-12-31 | 256138 | 1204564 Derived | -948426 | 394784 Derived | -1343210 | Unavailable | Source
|
| 2020 2020-01-01 – 2020-12-31 | 329500 | 3939078 Derived | -3609578 | 577739 Derived | -4187317 | Unavailable | Source
|
| 2021 2021-01-01 – 2021-12-31 | 354 | -76966 Derived | 77320 | 79322864 Derived | -79245544 | Unavailable | Source
|
| 2022 2022-01-01 – 2022-12-31 | 450000 | 16684000 Derived | -16234000 | 47000 Derived | -16281000 | Unavailable | Source
|
| 2023 2023-01-01 – 2023-12-31 | 504000 | 19689000 Derived | -19185000 | -673000 Derived | -18512000 | Unavailable | Source
|
| 2024 2024-01-01 – 2024-12-31 | 276000 | 9823000 Derived | -9547000 | -614000 Derived | -8933000 | Unavailable | Source
|
| 2025 2025-01-01 – 2025-12-31 | 1395000 | 8974000 Derived | -7579000 | 341000 Derived | -7920000 | Unavailable | Source
|
Amounts are exact, in USD.
Sales over time and how quickly they are changing.
Revenue reported for each complete financial period.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2018 | Revenue | 253785 |
|
| 2019 | Revenue | 256138 |
|
| 2020 | Revenue | 329500 |
|
| 2021 | Revenue | 354 |
|
| 2022 | Revenue | 450000 |
|
| 2023 | Revenue | 504000 |
|
| 2024 | Revenue | 276000 |
|
| 2025 | Revenue | 1395000 |
|
Change in revenue from the same financial period one year earlier.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2018 | Year over year | No prior comparable period |
|
| 2019 | Year over year | 0.9% |
|
| 2020 | Year over year | 28.6% |
|
| 2021 | Year over year | -99.9% |
|
| 2022 | Year over year | 127,018.6% |
|
| 2023 | Year over year | 12% |
|
| 2024 | Year over year | -45.2% |
|
| 2025 | Year over year | 405.4% |
|
How much revenue becomes profit, and how much cash operations generate.
Operating income, net income and free cash flow as a share of revenue.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2018 | Operating margin | -806.4% |
|
| 2019 | Operating margin | -370.3% |
|
| 2020 | Operating margin | -1,095.5% |
|
| 2021 | Operating margin | 21,841.8% |
|
| 2022 | Operating margin | -3,607.6% |
|
| 2023 | Operating margin | -3,806.5% |
|
| 2024 | Operating margin | -3,459.1% |
|
| 2025 | Operating margin | -543.3% |
|
| 2018 | Net margin | -989.5% |
|
| 2019 | Net margin | -524.4% |
|
| 2020 | Net margin | -1,270.8% |
|
| 2021 | Net margin | -22,385,746.9% |
|
| 2022 | Net margin | -3,618% |
|
| 2023 | Net margin | -3,673% |
|
| 2024 | Net margin | -3,236.6% |
|
| 2025 | Net margin | -567.7% |
|
| 2018 | Free cash flow margin | Not reported |
|
| 2019 | Free cash flow margin | Not reported |
|
| 2020 | Free cash flow margin | Not reported |
|
| 2021 | Free cash flow margin | Not reported |
|
| 2022 | Free cash flow margin | Not reported |
|
| 2023 | Free cash flow margin | Not reported |
|
| 2024 | Free cash flow margin | Not reported |
|
| 2025 | Free cash flow margin | Not reported |
|
Cash generated by the company’s normal business operations.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2018 | Operating cash flow | -192801 |
|
| 2019 | Operating cash flow | -760544 |
|
| 2020 | Operating cash flow | -591386 |
|
| 2021 | Operating cash flow | -1825 |
|
| 2022 | Operating cash flow | -8199000 |
|
| 2023 | Operating cash flow | -8859000 |
|
| 2024 | Operating cash flow | -7457000 |
|
| 2025 | Operating cash flow | -4889000 |
|
Operating cash flow minus capital expenditure for the same period and unit.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2018 | Free cash flow | Unavailable |
|
| 2019 | Free cash flow | Unavailable |
|
| 2020 | Free cash flow | Unavailable |
|
| 2021 | Free cash flow | Unavailable |
|
| 2022 | Free cash flow | Unavailable |
|
| 2023 | Free cash flow | Unavailable |
|
| 2024 | Free cash flow | Unavailable |
|
| 2025 | Free cash flow | Unavailable |
|
Liabilities and short-term ability to meet obligations at each period end.
Total liabilities as a share of total assets.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2018 | Liabilities / assets | 22,683% |
|
| 2019 | Liabilities / assets | 8,865.2% |
|
| 2020 | Liabilities / assets | 2,258.3% |
|
| 2021 | Liabilities / assets | 99.4% |
|
| 2022 | Liabilities / assets | 40.7% |
|
| 2023 | Liabilities / assets | 49.8% |
|
| 2024 | Liabilities / assets | 39.2% |
|
| 2025 | Liabilities / assets | 79.8% |
|
Current assets divided by current liabilities.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2018 | Current assets / current liabilities | 0× |
|
| 2019 | Current assets / current liabilities | 0.01× |
|
| 2020 | Current assets / current liabilities | 0.01× |
|
| 2021 | Current assets / current liabilities | 0.09× |
|
| 2022 | Current assets / current liabilities | 0.9× |
|
| 2023 | Current assets / current liabilities | 0.37× |
|
| 2024 | Current assets / current liabilities | 0.7× |
|
| 2025 | Current assets / current liabilities | 0.14× |
|
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2018 2018-01-01 – 2018-12-31 | −USD 2.51 million Exact valueExact value: -2511123 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 192,801 Exact valueExact value: -192801 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2019 2019-01-01 – 2019-12-31 | −USD 1.34 million Exact valueExact value: -1343210 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 760,544 Exact valueExact value: -760544 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2020 2020-01-01 – 2020-12-31 | −USD 4.19 million Exact valueExact value: -4187317 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 591,386 Exact valueExact value: -591386 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2021 2021-01-01 – 2021-12-31 | −USD 79.25 million Exact valueExact value: -79245544 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 1,825 Exact valueExact value: -1825 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2022 2022-01-01 – 2022-12-31 | −USD 16.28 million Exact valueExact value: -16281000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 8.2 million Exact valueExact value: -8199000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2023 2023-01-01 – 2023-12-31 | −USD 18.51 million Exact valueExact value: -18512000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 8.86 million Exact valueExact value: -8859000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2024 2024-01-01 – 2024-12-31 | −USD 8.93 million Exact valueExact value: -8933000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 7.46 million Exact valueExact value: -7457000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2025 2025-01-01 – 2025-12-31 | −USD 7.92 million Exact valueExact value: -7920000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 4.89 million Exact valueExact value: -4889000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
81 filings · 1,927 latest values · 1,927 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0001070050, 1070050, APCX, APCXW, edgar:1070050
Also known as AppTech Corp., AppTech Payments Corp., CSI Business Finance, Inc., HEALTH EXPRESS USA INC, Natural Nutrition Inc.